India-born Kiran Mazumdar-Shaw is an entrepreneur. She is the Chairman and Managing Director of Bengaluru-based Biocon Ltd., the largest biotechnology firm in India. She rose to become the richest woman in India in 2004. She received the Othmer Gold Medal in recognition of her exceptional contributions to the advancement of chemistry and science. The largest producer of insulin in Asia, Biocon Ltd., wants to capture ten percent of the world market. She received the Padma Bhushan (2005) and the Padmashri (1989) awards.
India's Bangalore was the place of Kiran Mazumdar-Shaw's birth on March 23, 1953. She was living in Bangalore, India, and came from a Gujarati family.Bishop's Cotton Girl's High School was where she finished her first education in 1968. In 1973, she completed her Bachelor of Science in Zoology with Honors from Mount Carmel College, Bangalore University. After two years, she earned her master's degree in brewing from Ballarat College and Melbourne University in Australia, where she had completed her postgraduate studies.
After four years, Kiran Mazumdar-Shaw started her professional career with Carlton & United Beverages in 1974 as a trainee brewer. She started working at Biocon Biochemicals Limited in Ireland in 1978 as a trainee manager.She also spent some time between 1975 and 1977 working as a technical manager at Standard Maltings Corporation in Baroda and as a technical consultant at Jupiter Breweries Limited in Calcutta. In cooperation with Biocon Biochemicals Limited, she established Biocon in India in 1978 with a meager 10,000 rupees as startup money. Notwithstanding the fact that it was a joint venture, Indian law limited foreign ownership to 30% of the business. Kiran Mazumdar Shaw owned the remaining 70%. At the time, biotechnology was not well-known in India, so all the banks she applied to obtain funding were cautious. Another uncommon concept for Indians was a female entrepreneur, and it was even more unusual when she entered a totally untapped market. She also had trouble finding employees for her fledgling company. A retired garage mechanic served as her first employment.
The first thing Biocon did was take an enzyme out of papaya. Biocon changed from being an industrial enzymes firm to an integrated biopharmaceutical company with strategic research efforts under Kiran Mazumdar Shaw's direction.As the first Indian business to do so, Biocon India was able to produce enzymes and ship them to the US and Europe within a year of its founding.With dreams of growing her business, Mazumdar utilized her first year's earnings to purchase a 20-acre property. She also founded two businesses. Clinigene (2000), which focuses on clinical research trials and the development of both new and generic medications, and Syngene (1994), which offers early research and development support services on a contract basis.Syngene and Clinigene eventually combined. 2015 saw Syngene go public on the BSE and NSE, and it currently has a $1.15 billion market valuation.
Currently, Biocon is acknowledged as the first biotech company in India. When Biocon decided to do an IPO in 2004, the offering was more than thirty times oversubscribed. Kiran Mazumdar Shaw, who was thought to be the richest woman in India with an estimated net worth of Rs. 2,100 crore, held about 40% of the company's shares after its initial public offering.
Kiran Mazumdar Shaw has won numerous esteemed accolades. These include the Ernst & Young Entrepreneur of the Year Award for Life Sciences & Healthcare, ET Businesswoman of the Year, Best Woman Entrepreneur, Model Employer, Leading Exporter, Outstanding Citizen, Technology Pioneer, and more. She served as the National Task Force on Biotechnology Chair and Mission Leader for the Confederation of Indian Industry. She was also a member of the Prime Minister's Council on Trade and Industry in India, the Science Foundation in Ireland, and the Board of Governors at IIM Bangalore.
She is listed among the top 50 women in business by the Financial Times. According to Forbes, she was the 85th most powerful woman in the world as of 2015.She has been featured on "Forbes" once more as the 77th most powerful woman in the world as of right now in 2016.
Posts
0 Comments